Peter Fickert
Impact in
- Hepatology top 0.1%
- Liver Diseases and Immunity
- Liver Disease and Transplantation
- Liver physiology and pathology
- Oncology top 0.5%
- Drug Transport and Resistance Mechanisms
Papers in
- Hepatology 87
- Liver Diseases and Immunity 51
- Liver Disease and Transplantation 33
- Liver physiology and pathology 10
- Oncology 79
- Drug Transport and Resistance Mechanisms 75
- Co-authors
- Michael TraunerMartin WagnerGernot ZollnerHelmut DenkAndrea FuchsbichlerKurt ZatloukalHanns–Ulrich MarschallDagmar Silbert
- Journals
- Journal of Hepatology (39 papers)Gastroenterology (14 papers)Hepatology (12 papers)Liver International (10 papers)Digestive Diseases (7 papers)
- Partner nations
- AustriaUnited StatesSweden
In The Last Decade
Peter Fickert
182 papers receiving 9.2k citations
Peers
Comparison fields: 5 of 120
- Hepatology 4.1k
- Oncology 4.1k
- Pharmacology 1.2k
- Epidemiology 4.0k
- Surgery 3.9k
Countries citing papers authored by Peter Fickert
This map shows the geographic impact of Peter Fickert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Peter Fickert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Peter Fickert more than expected).
Fields of papers citing papers by Peter Fickert
This network shows the impact of papers produced by Peter Fickert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Peter Fickert. The network helps show where Peter Fickert may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Peter Fickert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 3 | |
| 2 | 2023 | 2 | |
| 3 | 2022 | 10 | |
| 4 | 2021 | 11 | |
| 5 | 2021 | 22 | |
| 6 | 2020 | 3 | |
| 7 | 2019 | 49 | |
| 8 | 2019 | 55 | |
| 9 | 2018 | 3 | |
| 10 | 2017 | 68 | |
| 11 | 2016 | 49 | |
| 12 | norUrsodeoxycholic acid (norUDCA) improves cholestasis in primary sclerosing cholangitis (PSC) independent of ursodeoxycholic acid (UDCA) pre-treatment and response | 2016 | 4 |
| 13 | 2013 | 1 | |
| 14 | 2012 | 22 | |
| 15 | 2011 | 8 | |
| 16 | 2010 | 78 | |
| 17 | 2009 | 1 | |
| 18 | 2009 | 119 | |
| 19 | 2008 | 1 | |
| 20 | 2005 | 97 |
About Peter Fickert
Peter Fickert is a scholar working on Hepatology, Oncology, Epidemiology, Surgery and Pharmacology, having authored 188 papers that have together received 9.4k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (77 papers), Drug Transport and Resistance Mechanisms (75 papers), Pediatric Hepatobiliary Diseases and Treatments (52 papers), Liver Diseases and Immunity (51 papers), Liver Disease and Transplantation (33 papers), Drug-Induced Hepatotoxicity and Protection (12 papers), Gallbladder and Bile Duct Disorders (11 papers) and Liver physiology and pathology (10 papers). The work is most often cited by research in Hepatology (4.1k citations), Oncology (4.1k citations), Pharmacology (1.2k citations), Epidemiology (4.0k citations) and Surgery (3.9k citations). Peter Fickert has collaborated with scholars based in Austria, United States and Sweden. Frequent co-authors include Michael Trauner, Martin Wagner, Gernot Zollner, Helmut Denk, Andrea Fuchsbichler, Kurt Zatloukal, Hanns–Ulrich Marschall, Dagmar Silbert, Tarek Moustafa and Emina Halilbasic. Their work appears in journals such as Journal of Hepatology, Gastroenterology, Hepatology, Liver International and Digestive Diseases.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.